Income Statement Merck KGaA

Equities

MRK

DE0006599905

Pharmaceuticals

Market Closed - Xetra Other stock markets 16:35:01 22/01/2026 GMT			After hours 19:56:50
128.40 ^EUR	+3.46%		127.98	-0.33%

01-21	Merck: teams up with CEPI to make the Ebola vaccine more accessible in low-income countries
01-20	Merck CEO on US Business, Life Sciences Innovation	MT

d6584c7bdef0eb8c4.MLoXVQKNQhYufXChY4IuV-GtbTFSpT0Kz0U6FHr5dUI.B8I6Y2HKICFjSUbjM_BgBa3dLFgl33JEmyJWeyi9J3VeyUI_dOkjXGczJQ

Published financial data: MERCK KGAA

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	17.53B	19.69B	22.23B	20.99B	21.16B
Total Revenues	17.53B	19.69B	22.23B	20.99B	21.16B
Cost of Goods Sold, Total	6.78B	7.32B	8.5B	8.56B	8.63B
Gross Profit	10.75B	12.36B	13.74B	12.44B	12.52B
Selling General & Admin Expenses, Total	5.3B	5.47B	5.91B	5.78B	5.88B
Stock-Based Compensation (IS)	5M	3M	-7M	2M	11M
R&D Expenses	2.26B	2.4B	2.45B	2.44B	2.27B
Other Operating Expenses	117M	133M	372M	515M	274M
Other Operating Expenses, Total	7.68B	8.01B	8.72B	8.74B	8.44B
Operating Income	3.07B	4.35B	5.01B	3.7B	4.09B
Interest Expense, Total	-328M	-244M	-196M	-260M	-229M
Interest And Investment Income	39M	46M	71M	172M	164M
Net Interest Expenses	-289M	-198M	-125M	-88M	-65M
Currency Exchange Gains (Loss)	-60M	-40M	-109M	51M	20M
Other Non Operating Income (Expenses)	2M	14M	-3M	26M	30M
EBT, Excl. Unusual Items	2.73B	4.13B	4.78B	3.68B	4.07B
Restructuring Charges	-170M	-82M	-199M	-248M	-144M
Merger & Related Restructuring Charges	-190M	-119M	-83M	-	-
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	92M	63M	54M	132M	-3M
Asset Writedown	-183M	-54M	-232M	-98M	-328M
Legal Settlements	372M	8M	-6M	-1M	-48M
Other Unusual Items	-16M	-21M	-23M	15M	-11M
EBT, Incl. Unusual Items	2.63B	3.92B	4.29B	3.48B	3.54B
Income Tax Expense	637M	859M	948M	650M	751M
Earnings From Continuing Operations	1.99B	3.06B	3.34B	2.83B	2.79B
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	1.99B	3.06B	3.34B	2.83B	2.79B
Minority Interest	-7M	-10M	-14M	-10M	-9M
Net Income - (IS)	1.99B	3.06B	3.33B	2.82B	2.78B
Net Income to Common Incl Extra Items	1.99B	3.06B	3.33B	2.82B	2.78B
Net Income to Common Excl. Extra Items	1.99B	3.06B	3.33B	2.82B	2.78B
Per Share Items
Net EPS - Basic	4.57	7.03	7.65	6.5	6.39
Basic EPS - Continuing Operations	4.57	7.03	7.65	6.5	6.39
Basic Weighted Average Shares Outstanding	435M	435M	435M	435M	435M
Net EPS - Diluted	4.57	7.03	7.65	6.49	6.39
Diluted EPS - Continuing Operations	4.57	7.03	7.65	6.49	6.39
Diluted Weighted Average Shares Outstanding	435M	435M	435M	435M	435M
Normalized Basic EPS	3.9	5.91	6.83	5.27	5.83
Normalized Diluted EPS	3.9	5.91	6.83	5.27	5.83
Dividend Per Share	1.4	1.85	2.2	2.2	2.2
Payout Ratio	34.22	24.48	28.71	40.79	37.13
American Depositary Receipts Ratio (ADR)	0.2	0.2	0.2	0.2	0.2
Supplemental Items
EBITDA	4.59B	5.83B	6.56B	5.23B	5.78B
EBITA	3.93B	5.16B	5.84B	4.48B	4.8B
EBIT	3.07B	4.35B	5.01B	3.7B	4.09B
EBITDAR	4.61B	5.85B	6.57B	5.24B	5.79B
Effective Tax Rate - (Ratio)	24.21	21.89	22.11	18.66	21.23
Total Current Taxes	959M	1.08B	1.34B	1.14B	1.15B
Total Deferred Taxes	-333M	-174M	-369M	-323M	-257M
Normalized Net Income	1.7B	2.57B	2.97B	2.29B	2.54B
Interest Capitalized	8M	11M	17M	22M	38M
Interest on Long-Term Debt	15M	10M	13M	14M	25M
Non-Cash Pension Expense	45M	28M	44M	59M	64M
Supplemental Operating Expense Items
Advertising Expense	413M	461M	476M	515M	526M
Selling and Marketing Expenses	4.15B	4.29B	4.68B	4.47B	4.51B
General and Administrative Expenses	1.09B	1.16B	1.19B	1.26B	1.31B
Research And Development Expense From Footnotes	2.29B	2.41B	2.52B	2.44B	2.28B
Net Rental Expense, Total	18M	18M	14M	11M	8M
Imputed Operating Lease Interest Expense	3.82M	3.2M	2.25M	2.44M	1.69M
Imputed Operating Lease Depreciation	14.18M	14.8M	11.75M	8.56M	6.31M
Stock-Based Comp., Other (Total)	22.51M	3M	-7M	2M	11M
Total Stock-Based Compensation	22.51M	3M	-7M	2M	11M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	1.36B	1.9B	1.85B	1.98B	2.52B
Short Term Investments	1M	100M	203M	398M	558M
Trading Asset Securities, Total	12M	12M	42M	33M	-
Total Cash And Short Term Investments	1.37B	2.01B	2.1B	2.41B	3.08B
Accounts Receivable, Total	3.2B	3.72B	4.13B	3.98B	3.95B
Other Receivables	1.08B	1.05B	900M	928M	945M
Notes Receivable	-	-	-	1M	1M
Total Receivables	4.28B	4.77B	5.03B	4.9B	4.9B
Inventory	3.29B	3.9B	4.63B	4.64B	4.48B
Prepaid Expenses	151M	142M	210M	182M	169M
Other Current Assets, Total	189M	157M	226M	256M	822M
Total Current Assets	9.28B	10.98B	12.2B	12.39B	13.45B
Gross Property Plant And Equipment	13.23B	14.81B	16.51B	17.94B	19.11B
Accumulated Depreciation	-6.81B	-7.59B	-8.31B	-8.89B	-9.09B
Net Property Plant And Equipment	6.42B	7.22B	8.2B	9.06B	10.02B
Long-term Investments	539M	615M	675M	808M	964M
Goodwill	15.96B	17B	18.42B	17.84B	19.15B
Other Intangibles, Total	7.65B	7.61B	7.3B	6.55B	6.28B
Accounts Receivable Long-Term	-	-	-	-	-
Loans Receivable Long-Term	7M	4M	4M	4M	3M
Deferred Tax Assets Long-Term	1.54B	1.5B	1.31B	1.51B	1.31B
Other Long-Term Assets, Total	394M	426M	416M	324M	381M
Total Assets	41.8B	45.36B	48.53B	48.5B	51.57B
Liabilities
Accounts Payable, Total	1.1B	1.54B	1.6B	1.77B	1.5B
Accrued Expenses, Total	1.28B	1.56B	1.53B	1.49B	1.63B
Short-term Borrowings	1.02B	896M	-	-	-
Current Portion of Long-Term Debt	1.23B	1.52B	1.1B	580M	3.17B
Current Portion of Leases	112M	117M	125M	122M	137M
Current Income Taxes Payable	1.46B	1.42B	1.48B	1.43B	1.53B
Unearned Revenue Current, Total	304M	198M	282M	249M	203M
Other Current Liabilities	2.74B	3.18B	3.4B	3.06B	3.12B
Total Current Liabilities	9.23B	10.43B	9.51B	8.7B	11.29B
Long-Term Debt	9.46B	7.93B	8.83B	8.85B	6.37B
Long-Term Leases	327M	342M	366M	393M	625M
Unearned Revenue Non Current	47M	3M	3M	3M	3M
Pension & Other Post Retirement Benefits	3.88B	3.4B	2.03B	2.19B	1.96B
Deferred Tax Liability Non Current	1.44B	1.41B	1.28B	1.13B	892M
Other Non Current Liabilities	395M	428M	496M	477M	438M
Total Liabilities	24.78B	23.95B	22.52B	21.74B	21.58B
Common Stock, Total	565M	565M	565M	565M	565M
Additional Paid In Capital	3.81B	3.81B	3.81B	3.81B	3.81B
Retained Earnings	14.45B	16.61B	18.81B	20.63B	22.42B
Comprehensive Income and Other	-1.88B	349M	2.74B	1.67B	3.11B
Total Common Equity	16.95B	21.34B	25.93B	26.68B	29.91B
Minority Interest	71M	78M	78M	75M	75M
Total Equity	17.02B	21.42B	26B	26.76B	29.99B
Total Liabilities And Equity	41.8B	45.36B	48.53B	48.5B	51.57B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	435M	435M	435M	435M	435M
ECS Total Common Shares Outstanding	435M	435M	435M	435M	435M
Book Value / Share	38.98	49.08	59.63	61.36	68.8
Tangible Book Value	-6.67B	-3.28B	210M	2.28B	4.48B
Tangible Book Value Per Share	-15.33	-7.54	0.48	5.25	10.3
Total Debt	12.14B	10.8B	10.43B	9.94B	10.3B
Net Debt	10.77B	8.79B	8.33B	7.53B	7.23B
Debt Equivalent of Unfunded Proj. Benefit Obligation	3.56B	2.97B	1.63B	1.92B	1.63B
Debt Equivalent Oper. Leases	144M	144M	112M	88M	64M
Minority Interest, Total (Incl. Fin. Div)	71M	78M	78M	75M	75M
Equity Method Investments, Total	2M	3M	3M	3M	3M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	633M	814M	1.08B	1.16B	1.02B
Inventories - Work In Process, Total	905M	990M	1.42B	1.43B	1.46B
Inventories - Finished Goods, Total	1.76B	2.1B	2.14B	2.04B	2B
Land - (BS)	4.97B	5.46B	5.98B	6.33B	7.48B
Machinery, Total	5.25B	5.69B	6.23B	6.63B	7.08B
Full Time Employees	55.22K	60.33K	64.23K	62.91K	59.02K
Part Time Employees	2.91K	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	73M	59M	63M	97M	101M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	1.99B	3.06B	3.33B	2.82B	2.78B
Depreciation & Amortization - CF	815M	814M	866M	895M	982M
Amortization of Goodwill and Intangible Assets - (CF)	858M	803M	830M	783M	714M
Depreciation & Amortization, Total	1.67B	1.62B	1.7B	1.68B	1.7B
Amortization of Deferred Charges, Total - (CF)	82M	90M	102M	104M	110M
(Gain) Loss From Sale Of Asset	-98M	-24M	-48M	-150M	-2M
Asset Writedown & Restructuring Costs	183M	55M	232M	98M	328M
Other Operating Activities, Total	45M	97M	33M	-63M	-13M
Change In Accounts Receivable	-84M	-310M	-413M	-8M	79M
Change In Inventories	-85M	-472M	-604M	-89M	36M
Change In Accounts Payable	7M	433M	101M	-43M	-178M
Change in Other Net Operating Assets	-233M	75M	-166M	-567M	-247M
Cash from Operations	3.48B	4.62B	4.26B	3.78B	4.59B
Capital Expenditure	-1.41B	-1.07B	-1.53B	-1.81B	-1.7B
Sale of Property, Plant, and Equipment	90M	7M	21M	19M	27M
Cash Acquisitions	-11M	-4M	-854M	-12M	-774M
Divestitures	-8M	1M	4M	-	7M
Sale (Purchase) of Intangible assets	-62M	-316M	-237M	-80M	-464M
Investment in Marketable and Equity Securities, Total	62M	-200M	-145M	-27M	-
Other Investing Activities, Total	2M	-	-1M	15M	-144M
Cash from Investing	-1.34B	-1.58B	-2.74B	-1.89B	-3.05B
Short Term Debt Issued, Total	390M	471M	-	-	683M
Long-Term Debt Issued, Total	6.05B	388M	3.91B	1.22B	2.11B
Total Debt Issued	6.44B	859M	3.91B	1.22B	2.8B
Short Term Debt Repaid, Total	-382M	-393M	-1.61B	-420M	-453M
Long-Term Debt Repaid, Total	-6.89B	-2.21B	-2.89B	-1.36B	-2.29B
Total Debt Repaid	-7.27B	-2.61B	-4.5B	-1.78B	-2.74B
Common Dividends Paid	-680M	-748M	-955M	-1.15B	-1.03B
Common & Preferred Stock Dividends Paid	-680M	-748M	-955M	-1.15B	-1.03B
Other Financing Activities, Total	-7M	-9M	-12M	-12M	-7M
Cash from Financing	-1.52B	-2.5B	-1.56B	-1.73B	-985M
Foreign Exchange Rate Adjustments	-40M	9M	-7M	-31M	-16M
Miscellaneous Cash Flow Adjustments	-	-	1M	-1M	-
Net Change in Cash	575M	543M	-45M	128M	535M
Supplemental Items
Cash Interest Paid	340M	216M	185M	181M	240M
Cash Income Tax Paid (Refund)	866M	1.04B	1.2B	1.02B	957M
Levered Free Cash Flow	1.88B	2.86B	2.29B	1.88B	1.66B
Unlevered Free Cash Flow	2.09B	3.02B	2.41B	2.04B	1.8B
Change In Net Working Capital	137M	32M	747M	167M	402M
Net Debt Issued / Repaid	-835M	-1.75B	-588M	-568M	53M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	4.49	6.24	6.68	4.76	5.1
Return on Total Capital	6.37	8.87	9.13	6.32	6.63
Return On Equity %	11.42	15.95	14.09	10.74	9.82
Return on Common Equity	11.42	15.96	14.07	10.74	9.81
Margin Analysis
Gross Profit Margin %	61.32	62.79	61.79	59.23	59.2
SG&A Margin	30.2	27.8	26.59	27.55	27.81
EBITDA Margin %	26.19	29.61	29.5	24.89	27.33
EBITA Margin %	22.42	26.19	26.29	21.33	22.69
EBIT Margin %	17.53	22.11	22.55	17.6	19.31
Income From Continuing Operations Margin %	11.37	15.57	15.02	13.5	13.17
Net Income Margin %	11.33	15.52	14.96	13.45	13.13
Net Avail. For Common Margin %	11.33	15.52	14.96	13.45	13.13
Normalized Net Income Margin	9.68	13.06	13.37	10.92	11.98
Levered Free Cash Flow Margin	10.73	14.55	10.29	8.94	7.84
Unlevered Free Cash Flow Margin	11.9	15.32	10.84	9.71	8.52
Asset Turnover
Asset Turnover	0.41	0.45	0.47	0.43	0.42
Fixed Assets Turnover	2.78	2.89	2.88	2.43	2.22
Receivables Turnover (Average Receivables)	5.39	5.67	5.66	5.18	5.34
Inventory Turnover (Average Inventory)	2.04	2.04	1.99	1.85	1.89
Short Term Liquidity
Current Ratio	1.01	1.05	1.28	1.42	1.19
Quick Ratio	0.61	0.65	0.75	0.84	0.71
Operating Cash Flow to Current Liabilities	0.38	0.44	0.45	0.43	0.41
Days Sales Outstanding (Average Receivables)	67.92	64.38	64.51	70.5	68.59
Days Outstanding Inventory (Average Inventory)	179.06	179.24	183.29	197.66	193.37
Average Days Payable Outstanding	67.29	60.68	62.05	71.74	70.62
Cash Conversion Cycle (Average Days)	179.7	182.94	185.75	196.43	191.34
Long Term Solvency
Total Debt/Equity	71.35	50.43	40.1	37.16	34.35
Total Debt / Total Capital	41.64	33.53	28.62	27.09	25.57
LT Debt/Equity	57.5	38.62	35.38	34.53	23.33
Long-Term Debt / Total Capital	33.56	25.67	25.25	25.18	17.37
Total Liabilities / Total Assets	59.29	52.79	46.41	44.83	41.85
EBIT / Interest Expense	9.37	17.84	25.58	14.21	17.84
EBITDA / Interest Expense	14.47	24.47	34.23	20.67	25.25
(EBITDA - Capex) / Interest Expense	10.16	20.1	26.42	13.72	17.82
Total Debt / EBITDA	2.56	1.81	1.55	1.85	1.78
Net Debt / EBITDA	2.27	1.47	1.24	1.4	1.25
Total Debt / (EBITDA - Capex)	3.64	2.2	2.01	2.79	2.52
Net Debt / (EBITDA - Capex)	3.23	1.79	1.61	2.11	1.77
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	8.56	12.28	12.93	-5.57	0.78
Gross Profit, 1 Yr. Growth %	5.4	14.97	11.12	-9.45	0.72
EBITDA, 1 Yr. Growth %	8.48	26.99	13.3	-19.87	7.51
EBITA, 1 Yr. Growth %	7.02	31.23	14.39	-22.9	7.07
EBIT, 1 Yr. Growth %	20.37	41.75	16.44	-25.77	10.43
Earnings From Cont. Operations, 1 Yr. Growth %	53.98	53.71	8.97	-15.15	-1.69
Net Income, 1 Yr. Growth %	50.53	53.75	8.87	-15.09	-1.66
Normalized Net Income, 1 Yr. Growth %	27.8	51.61	16.79	-22.27	10.44
Diluted EPS Before Extra, 1 Yr. Growth %	53.87	53.75	8.87	-15.16	-1.58
Accounts Receivable, 1 Yr. Growth %	-3.15	15.62	11.01	-3.82	-0.55
Inventory, 1 Yr. Growth %	-1.44	18.4	18.77	0.11	-3.3
Net Property, Plant and Equip., 1 Yr. Growth %	3.7	12.4	13.66	10.39	10.7
Total Assets, 1 Yr. Growth %	-4.59	8.53	6.98	-0.08	6.33
Tangible Book Value, 1 Yr. Growth %	-21.52	-50.83	-106.41	1.03K	96.15
Common Equity, 1 Yr. Growth %	-5.02	25.92	21.51	2.9	12.11
Cash From Operations, 1 Yr. Growth %	21.74	32.76	-7.73	-11.15	21.19
Capital Expenditures, 1 Yr. Growth %	73.8	-24.56	43.62	18.03	-5.81
Levered Free Cash Flow, 1 Yr. Growth %	-10.24	53.79	-19.44	-17.16	-11.72
Unlevered Free Cash Flow, 1 Yr. Growth %	-11.14	45.92	-19.47	-14.61	-11.74
Dividend Per Share, 1 Yr. Growth %	7.69	32.14	18.92	0	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	8.71	10.4	12.6	3.26	-2.45
Gross Profit, 2 Yr. CAGR %	6.42	10.08	13.03	0.29	-4.5
EBITDA, 2 Yr. CAGR %	11.79	17.34	19.52	-4.98	-5.84
EBITA, 2 Yr. CAGR %	11.68	18.48	21.96	-6.38	-9.09
EBIT, 2 Yr. CAGR %	24.64	30.58	27.78	-7.37	-9.4
Earnings From Cont. Operations, 2 Yr. CAGR %	35.07	53.84	29.42	-3.84	-8.67
Net Income, 2 Yr. CAGR %	-23.26	52.13	29.38	-3.86	-8.63
Normalized Net Income, 2 Yr. CAGR %	26.9	39.15	32.39	-5.08	-7.28
Diluted EPS Before Extra, 2 Yr. CAGR %	36.21	53.81	29.38	-3.89	-8.63
Accounts Receivable, 2 Yr. CAGR %	3.97	6.13	13.29	3.33	-2.2
Inventory, 2 Yr. CAGR %	9.17	8.03	18.58	9.04	-1.61
Net Property, Plant and Equip., 2 Yr. CAGR %	15.53	7.96	13.03	12.02	10.54
Total Assets, 2 Yr. CAGR %	6.44	1.76	7.75	3.4	3.08
Tangible Book Value, 2 Yr. CAGR %	32.43	-37.88	-82.25	-16.53	369.78
Common Equity, 2 Yr. CAGR %	-0.74	9.36	23.69	11.82	7.41
Cash From Operations, 2 Yr. CAGR %	25.18	27.13	10.68	-9.46	3.77
Capital Expenditures, 2 Yr. CAGR %	24.61	14.51	4.09	30.2	5.44
Levered Free Cash Flow, 2 Yr. CAGR %	-6.13	16.9	10.82	-18.69	-14.41
Unlevered Free Cash Flow, 2 Yr. CAGR %	-4.81	13.36	7.96	-17.44	-13.12
Dividend Per Share, 2 Yr. CAGR %	5.83	19.29	25.36	9.05	0
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	6.5	9.89	11.24	6.19	2.43
Gross Profit, 3 Yr. CAGR %	4.28	9.2	10.43	4.97	0.43
EBITDA, 3 Yr. CAGR %	1.51	16.63	15.7	4.41	-0.03
EBITA, 3 Yr. CAGR %	0.59	17.83	16.74	4.46	-2.06
EBIT, 3 Yr. CAGR %	4.93	30.07	25.23	6.36	-1.73
Earnings From Cont. Operations, 3 Yr. CAGR %	-7.97	41.02	37.14	12.43	-3.13
Net Income, 3 Yr. CAGR %	-8.63	-3.26	36.08	12.43	-3.13
Normalized Net Income, 3 Yr. CAGR %	4.21	34.62	30.81	10.58	-0.12
Diluted EPS Before Extra, 3 Yr. CAGR %	-7.95	41.82	37.08	12.4	-3.13
Accounts Receivable, 3 Yr. CAGR %	3.09	7.93	7.73	7.27	2.02
Inventory, 3 Yr. CAGR %	7.77	12.16	11.49	12.07	4.76
Net Property, Plant and Equip., 3 Yr. CAGR %	12.48	14.47	9.83	12.14	11.58
Total Assets, 3 Yr. CAGR %	5.47	7.14	3.47	5.08	4.37
Tangible Book Value, 3 Yr. CAGR %	-5.49	-4.81	-70.87	-30.02	10.97
Common Equity, 3 Yr. CAGR %	6.57	7.45	13.27	16.33	11.92
Cash From Operations, 3 Yr. CAGR %	8.85	27.65	14.25	2.86	-0.22
Capital Expenditures, 3 Yr. CAGR %	15.42	5.42	23.49	8.54	16.88
Levered Free Cash Flow, 3 Yr. CAGR %	-7.04	10.29	2.96	0.26	-16.39
Unlevered Free Cash Flow, 3 Yr. CAGR %	-6.18	9.43	0.87	-0.45	-15.54
Dividend Per Share, 3 Yr. CAGR %	3.85	13.96	19.17	16.26	5.95
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	6.42	5.56	8.9	7.19	5.55
Gross Profit, 5 Yr. CAGR %	4.09	4.71	7.7	5.55	4.19
EBITDA, 5 Yr. CAGR %	5.12	6.76	8.35	7.3	6.43
EBITA, 5 Yr. CAGR %	4.33	7.01	8.64	7.28	5.5
EBIT, 5 Yr. CAGR %	6.6	12.12	13.52	13.31	9.86
Earnings From Cont. Operations, 5 Yr. CAGR %	12.27	13.42	5.48	20.99	16.56
Net Income, 5 Yr. CAGR %	12.25	13.4	5.01	-3.5	16.04
Normalized Net Income, 5 Yr. CAGR %	7.9	14.2	14.66	16.82	13.81
Diluted EPS Before Extra, 5 Yr. CAGR %	12.41	13.38	5.48	21.38	16.55
Accounts Receivable, 5 Yr. CAGR %	3.18	5.21	7.18	6.06	3.64
Inventory, 5 Yr. CAGR %	4.77	8.37	11.97	10.9	6.06
Net Property, Plant and Equip., 5 Yr. CAGR %	9.88	11.27	12.7	13.49	10.12
Total Assets, 5 Yr. CAGR %	1.88	3.47	6.38	5.62	3.32
Tangible Book Value, 5 Yr. CAGR %	-11.85	-21.51	-51.59	-9.69	-12.01
Common Equity, 5 Yr. CAGR %	5.79	8.81	13.11	9.18	10.89
Cash From Operations, 5 Yr. CAGR %	9.64	12.89	9.58	11.26	9.93
Capital Expenditures, 5 Yr. CAGR %	22.42	8.29	10.75	14.71	15.92
Levered Free Cash Flow, 5 Yr. CAGR %	0.68	4.36	-0.47	-2.54	-4.56
Unlevered Free Cash Flow, 5 Yr. CAGR %	0.77	3.87	-0.94	-2.4	-5.15
Dividend Per Share, 5 Yr. CAGR %	5.92	9.04	11.97	11.97	11.1